GenOway to Supply a US Pharma With Genetically Modified Murine Lines | GenomeWeb
NEW YORK (GenomeWeb News) — GenOway will supply “a leading” but undisclosed US pharmaceutical company with its genetically modified mouse lines in exchange for up to $2 million, the firm said yesterday.
 
GenOway makes a line of genetically modified mouse and rat lines, and uses knowledge in transgenic technologies including pronuclear microinjection, knock-out, knock-in, knock-down, point mutation, in vivo drug screening, drug efficacy, and safety testing.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.